Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Imbs JL, Castot A, Begaud B, Larousse C, Blayac JP, Alexandre JM. Le système francais de pharmacovigilance [French system of drug surveillance]. Bull Acad Natl Med. 1998;182:1383–91.
2. Létinier L, Jouganous J, Benkebil M, Bel-Létoile A, Goehrs C, Singier A, et al. Artificial intelligence for unstructured healthcare data: application to coding of patient reporting of adverse drug reactions. Clin Pharmacol Ther. 2021;110:392–400.
3. Ball R, Dal Pan G. “Artificial Intelligence” for pharmacovigilance: ready for prime time? Drug Saf. 2022;45:429–38.
4. Wang H, Ding YJ, Luo Y. Future of ChatGPT in pharmacovigilance. Drug Saf. 2023;46:711–3.
5. Lombardo S, Cosentino M. Internet use for searching information on medicines and disease: a community pharmacy-based survey among adult pharmacy customers. Interact J Med Res. 2016;5: e22. https://doi.org/10.2196/ijmr.5231.